← All decks

Anaesthesiology

The Liver Surgery and Anesthesia

Built from Barash Clinical Anesthesia, 9th Edition

What’s inside

9 sections · 198 slides

  1. 01

    Overview

    • Scope and core messages

    1 slide

  2. 02

    The healthy liver

    • Size, position and functional unit of the liver
    • Blood and bile flow through the liver lobule
    • Dual blood supply and portal pressure
    • Hepatic arterial buffer response
    • Lobular zones and Kupffer cells
    • Carbohydrate and fat metabolism in the liver
    • Protein and clotting factor synthesis
    • Ammonia handling and urea formation
    • Bile formation, enterohepatic circulation and cholestasis
    • Liver, gallbladder and bile duct anatomy
    • Liver regeneration
    • Vessels branching inside the liver

    12 slides

  3. 03

    Measuring liver function

    • What AST and ALT actually measure
    • The AST to ALT ratio
    • Markers of obstructed bile flow
    • Bilirubin fractions and the ceiling in obstruction
    • Albumin, prothrombin time and INR as tests of synthesis
    • Research tests and reading the panel as a pattern
    • Ancillary tests for specific diagnoses
    • Blood tests and the differential diagnosis of hepatic dysfunction
    • Ultrasound, plain films and radioisotope scanning
    • Computed tomography and magnetic resonance imaging
    • Cholangiography, ERCP and liver biopsy

    11 slides

  4. 04

    Liver diseases

    • Burden of liver disease and the anatomical divide
    • Hepatocellular versus biliary disease
    • Acute liver failure: definition, causes and outcome
    • Initial assessment of suspected acute liver failure
    • Initial laboratory panel in acute liver failure
    • Initial laboratory analysis of suspected acute liver failure
    • Initial laboratory analysis of suspected acute liver failure (continued)
    • Systemic effects and encephalopathy grading
    • Grades of encephalopathy
    • Mechanism of cerebral oedema in liver failure
    • Contributors to oedema and ammonia-lowering therapy
    • Reducing cerebral oedema in acute liver failure
    • Steroids, antibiotics and the cerebral perfusion target
    • Monitoring intracranial pressure in acute liver failure
    • Intracranial pressure management protocol
    • Prognostic models in acute liver failure
    • King's College selection criteria for liver transplantation by cause of acute liver failure
    • Bleeding risk and factor concentrates in acute liver failure
    • Hypotension in acute liver failure
    • The hepatitis viruses and how they present
    • Hepatitis A and hepatitis B
    • Hepatitis D and hepatitis C
    • Alcoholic hepatitis: features and treatment
    • Mallory hyalin in alcoholic liver disease
    • Drug-induced liver injury
    • Mechanisms of drug-induced liver injury
    • Halothane and the National Halothane Study
    • The two forms of halothane hepatitis
    • Metabolism and hepatitis risk of halogenated agents
    • Liver disease in pregnancy and hyperemesis gravidarum
    • Intrahepatic cholestasis of pregnancy
    • Preeclampsia, HELLP syndrome and its laboratory findings
    • Hepatic injury in HELLP syndrome
    • Management of hepatic complications in HELLP
    • Acute fatty liver of pregnancy
    • Comparing the pregnancy-specific liver diseases
    • Distinguishing intrahepatic cholestasis of pregnancy, HELLP syndrome and acute fatty liver of pregnancy
    • Distinguishing intrahepatic cholestasis of pregnancy, HELLP syndrome and acute fatty liver of pregnancy (continued)
    • Distinguishing intrahepatic cholestasis of pregnancy, HELLP syndrome and acute fatty liver of pregnancy (continued)
    • Distinguishing intrahepatic cholestasis of pregnancy, HELLP syndrome and acute fatty liver of pregnancy (continued)

    40 slides

  5. 05

    Cirrhosis and portal hypertension

    • Chronic liver disease burden and portal hypertension thresholds
    • Development of cirrhosis
    • Nodular surface of a cirrhotic liver
    • Haemostasis in liver disease and why PT misleads
    • Rebalanced haemostasis and thrombosis risk
    • Cholestatic coagulopathy and dysfibrinogenemia
    • Thrombocytopenia and thrombin generation in cirrhosis
    • Fibrinolysis in end-stage liver disease
    • DIC and accelerated intravascular coagulation in liver disease
    • The hyperdynamic circulation of cirrhosis
    • The four components of cirrhotic cardiomyopathy
    • Cirrhotic cardiomyopathy and coronary artery disease
    • Diastolic dysfunction, autonomic neuropathy and QTc
    • Cardiac testing limits and renal dysfunction in cirrhosis
    • Non-hepatorenal kidney disease in cirrhosis
    • Neurohormonal activation in cirrhosis
    • Nephrotoxic drugs and assessing volume in cirrhosis
    • Hepatorenal syndrome: frequency and precipitants
    • HRS-AKI and HRS-CKD
    • Why upstream therapy works, and combined transplantation
    • Treating hepatorenal syndrome
    • Breathlessness in liver disease and orthodeoxia
    • Hepatopulmonary syndrome: criteria and detection
    • Types of intrapulmonary vascular dilatation
    • Mechanism of hypoxaemia in hepatopulmonary syndrome
    • Hepatopulmonary syndrome outcome and POPH definition
    • Criteria for portopulmonary hypertension
    • POPH epidemiology and transplantation thresholds
    • Screening and confirming portopulmonary hypertension
    • Drug therapy for portopulmonary hypertension
    • Hepatic encephalopathy and its differential diagnosis
    • Diagnosing overt hepatic encephalopathy
    • Pathogenesis of hepatic encephalopathy
    • Searching for a precipitating factor
    • Precipitating factors in hepatic encephalopathy
    • Precipitating factors in hepatic encephalopathy (continued)
    • Lactulose in hepatic encephalopathy
    • Protein intake and zinc in hepatic encephalopathy
    • Ascites and the serum-ascites albumin gradient
    • Treating ascites and correcting sodium safely
    • Refractory ascites and albumin replacement
    • TIPS and peritoneovenous shunting for ascites
    • Spontaneous bacterial peritonitis
    • Formation of varices
    • Esophageal varices and endoscopic banding
    • Measuring portal pressure and diagnosing varices
    • Management of acute variceal bleeding
    • Hepatocellular carcinoma
    • Treatment options in hepatocellular carcinoma
    • Nonalcoholic fatty liver disease and steatohepatitis
    • Biliary obstruction and hypercoagulability
    • Kidney injury in cholestasis
    • Primary biliary cirrhosis and primary sclerosing cholangitis
    • PSC complications and the preoperative history

    54 slides

  6. 06

    Preoperative assessment

    • Physical signs of active liver disease
    • Against routine preoperative liver testing
    • Substantial enzyme elevation and acute hepatitis
    • The Child-Turcotte-Pugh classification and its scoring
    • Modified Child-Pugh score
    • Mortality by Child class
    • The MELD score and its predictive accuracy
    • MELD score formula
    • Mortality per MELD point
    • Beyond MELD: extra predictors and the VOCAL-Penn score
    • MELD thresholds for surgical decision-making
    • Medical optimisation and viscoelastic coagulation testing
    • Operative site and cumulative risk factors
    • Laparoscopic surgery and preoperative TIPS in cirrhosis

    14 slides

  7. 07

    Intraoperative management

    • Monitoring and vascular access in liver disease
    • Neuraxial and regional technique in liver disease
    • Volatile anesthetics and hepatic blood flow
    • Reactive metabolites and repeat exposure
    • Sevoflurane and cross-sensitisation
    • Nitrous oxide and intravenous anesthetics
    • Opioids in liver disease
    • Hepatic drug clearance and protein binding
    • Extraction ratio and its consequences
    • Pharmacodynamic sensitivity and organ-independent blockers
    • Induction agents and neuromuscular blockers
    • Vasopressor responsiveness and the TIPS procedure
    • Albumin in volume resuscitation
    • Transjugular intrahepatic portosystemic shunt
    • Anesthesia and complications of the TIPS procedure
    • History of liver surgery
    • Couinaud segmental anatomy of the liver
    • Mortality and technique in hepatic resection
    • Blood loss control during hepatic resection
    • Ischaemic preconditioning versus intermittent clamping
    • Air embolism and coagulation after liver resection
    • Analgesia and evolving techniques after liver resection

    22 slides

  8. 08

    Postoperative liver dysfunction

    • Postoperative liver dysfunction: presentation and time course
    • Hepatic hypoxaemia and bilirubin load after surgery
    • Lead-in to the causes of postoperative liver dysfunction
    • Causes of postoperative liver dysfunction
    • Unconjugated hyperbilirubinemia after surgery
    • Conjugated hyperbilirubinemia and cardiac surgery in cirrhosis
    • Causes of hyperbilirubinemia
    • Site of surgery and renal failure as risk factors
    • Mortality after hepatic resection by underlying liver state

    9 slides

  9. 09

    Putting it together

    • Timing of elective surgery in liver disease
    • Where to operate and what technique to choose
    • Ten facts to carry away
    • Further facts to carry away
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Barash, Cullen, and Stoelting's Clinical Anesthesia, 9th Edition

    27 slides